Newly Diagnosed Multiple Myeloma: Latest in Transplant Eligible Setting

In part one of the Multiple Myeloma Today roundtable series discussing newly diagnosed multiple myeloma, moderator Dr. Saad Usmani and Dr. Cesar Rodriguez review recent research presented at ASH 2021. Together, they cover the latest on newly diagnosed multiple myeloma and isatuximab therapies, including the GRIFFIN study.